Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Ketamine vs Opioids for Acute Pain in ED Patients With Long Bone Fractures
NCT04061330Phase 2Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ketamine in acute pain (2 arms), sponsored by UTHealth Houston. Primary endpoint: Numerical pain rating score at 6 hours. Planned start Jan 2022; status: withdrawn.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04061330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04061330.